Is radiographic progression in modern rheumatoid arthritis trials still a robust outcome? Experience from tofacitinib clinical trials

Modified total Sharp scoreMissing dataOutlierPrognostic factorsRadiographic progressionRheumatoid arthritisTofacitinibSensitivity analyses